The Chemours Company (CC)

Every figure this model derived for CC, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 179,000,000 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 671,000,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 3,094,000,000 AssetsCurrent 2026-06-30
current liabilities 1,861,000,000 LiabilitiesCurrent 2026-06-30
equity -49,000,000 StockholdersEquity 2026-06-30
interest expense 273,000,000 InterestExpense 2026-06-30
ocf 397,000,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 5,796,000,000 RevenueFromContractWithCustomerExcludingAssessedTax 2026-06-30
sbc 23,000,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up CC on one particular measure came for.

RatioValue
cash operating margin88.92
current ratio1.66
current ratio reported1.66
deferred revenue growth-57.14
dilution pct0.04
ebit cagr-6.06
ebit yoy1.8
ev ebit1.16
ev owner earnings28.67
ev sales0.96
fcf margin3.76
growth cv3.35
interest cover17.62
net debt ebitda0.62
operating margin83.01
owner earnings margin3.36
revenue growth-0.92
revenue growth per share-0.97
roic120.58
rpo growth-41.35
rule of 4082.08
sbc pct revenue0.4

What to be careful about

What this model itself distrusts about CC's figures. Written by the derivation as it ran, not added afterwards.